Search results
Showing results for
The 5-year programme award will support research on the DNA repair mechanisms that protect cancer cells from therapy, informing the development of future therapies.
Diagnostic Implications of Multi-Cancer Early Detection Testing in the Investigation of Cancer Symptoms: An Exploratory Retrospective Analysis of the SYMPLIFY Study.
Journal article
Jackson A. et al, (2026), Lancet Reg Health Eur, 66
CT radiomics for survival risk stratification in resectable colorectal liver metastases: a multi-centre study
Journal article
Mian A. et al, (2026), Scientific Reports, 16
Pragmatism in academic gastrointestinal cancer clinical trials: An analysis of trials conducted by the EORTC gastrointestinal tract cancer group and the unicancer gastrointestinal group.
Journal article
Puhr HC. et al, (2026), Eur J Cancer, 241
Supplementary Figure 5 from Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis
Other
Woolley CE. et al, (2026)
Supplementary Figure 1 from Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis
Other
Woolley CE. et al, (2026)
Supplementary Table 7 from Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis
Other
Woolley CE. et al, (2026)
Supplementary Table 8 from Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis
Other
Woolley CE. et al, (2026)
Supplementary Table 2 from Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis
Other
Woolley CE. et al, (2026)
Supplementary Table 6 from Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis
Other
Woolley CE. et al, (2026)
Supplementary Table 5 from Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis
Other
Woolley CE. et al, (2026)
Supplementary Figure 2 from Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis
Other
Woolley CE. et al, (2026)
Supplementary Table 3 from Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis
Other
Woolley CE. et al, (2026)
Supplementary Figure 2 from The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine
Other
Hashimoto T. et al, (2026)
Supplementary Figure 3 from Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis
Other
Woolley CE. et al, (2026)
Supplementary Table 1 from Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis
Other
Woolley CE. et al, (2026)
Supplementary Table 1 from The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine
Other
Hashimoto T. et al, (2026)
Supplementary Table 3 from The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine
Other
Hashimoto T. et al, (2026)
Supplementary Figure 4 from Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis
Other
Woolley CE. et al, (2026)